Table 4.

Cox proportional hazards modeling of baseline and time-dependent variables associated with mortality between 1 and 5 yr after ART initiation

^*Compared with patients who had no comorbidity (reference); ^†including both AIDS and non-AIDS malignancy; ^‡Compared with patients who had no history of mono/dual therapy (reference). HR, hazard ratio; aHR, adjusted hazard ratio; CI, confidence interval; HIV, human immunodeficiency virus; ART, anti-retroviral therapy; IDU, injection drug user; PI, protease inhibitor; NNRTI, non-nucleotide reverse transcriptase inhibitor; HBV, hepatitis B virus; HCV, hepatitis C virus.